Healthcare Realty Trust Incorporated HR
Composite 37/100; the shares have moved about 20% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Balance-sheet strength ranks 17/100 — a strong mark against it.
Income ranks 91/100 — a strong point in its favour. Momentum ranks 52/100 — a slight point in its favour.
Balance-sheet strength ranks 17/100 — a strong mark against it. Quality ranks 31/100 — a moderate mark against it. Growth ranks 35/100 — a moderate mark against it.
What the company does Healthcare Realty Trust Incorporated (HR) owns and operates 579 medical outpatient buildings near leading hospital campuses across 28 states, totaling 33.6 million square feet as of September 30, 2025.
Key financials ROE -4.2%, ROA 0.7%, and ROCE -0.1% reflect weak profitability despite revenue of $62.0% gross margin. Net margin is -17.3%, with revenue growth at -6.5% and EPS down -76.8%. Debt/Equity stands at 0.97 and net debt/EBITDA at 6.20, while interest coverage is -0.06.
Stock health Sideravia scores HR poorly on quality (28.9) and growth (15.5), but momentum is strong (78.1) with 12-month returns at 43.30%. The dividend yield is 4.5%, though payout ratio is high at 251.5%.
Price vs fair value HR trades at a **discount of 38.50%** to our fair-value estimate of 29.81 and a **PREMIUM of 0.91%** to the 12-month target of 21.33. - Q2 FFO and revenues beat estimates (Zacks) - Valuation percentile of 34.3/100 suggests rich pricing (Sideravia) - Piotroski F-Score of 8/9 indicates strong financial health (Sideravia)
Looking forward Forward P/E of 10.83 and EV/EBITDA of 20.18 imply moderate valuation, but weak fundamentals (ROE, ROA) and high leverage remain concerns. Momentum may persist, but profitability trends need monitoring.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.